Bio:

Avi (Avinash) Sahu is a multidisciplinary researcher bridging mathematics, engineering, statistics, and biology to revolutionize how we understand and treat cancer. Recognized by the Michelson Prize, the NCI K99 Young Investigator Award, and the Irving Foundation’s “40 most promising young Cancer Immunology scientists,” he develops AI and probabilistic methods that illuminate the tumor–immune microenvironment at a systems level. His group’s breakthroughs include uncovering bipotent anticancer drugs, novel genetic interactions driving treatment response, and Bayesian approaches that reveal hidden determinants of disease. Trained internationally (Harvard, India, France, Switzerland, Germany, Israel), Avi collaborates with leading labs and industry partners to translate cutting-edge analytics into life-changing therapies. He is equally committed to mentoring the next generation of scientists—particularly those overcoming challenging backgrounds—to unlock their potential through hard work, rigor, and curiosity.